Pes anserine bursitis. Other bursitis of knee
Conditions
Interventions
Intervention 1: In intervention group, in addition to receive naproxen (500 mg q 12 hrs) or diclofenac (75 mg per day) and pantoprazole (40 mg per day) for 2 weeks, weight loss, avoid to kneeling down
Behavior
In intervention group, in addition to receive naproxen (500 mg q 12 hrs) or diclofenac (75 mg per day) and pantoprazole (40 mg per day) for 2 weeks, weight loss, avoid to kneeling down and sitting cro
In control group, patients receive naproxen (500 mg q 12 hrs) or diclofenac (75 mg per day) and pantoprazole (40 mg per day) for 2 weeks, weight loss, avoid to kneeling down and sitting crossed leg, q
Sponsors
Semnan University of Medical Sciences, Vice Chancellor for Research and Technology
Eligibility
Sex/Gender
Female
Age
50 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 50 to 60 years old female with BMI=25 - 30 kg/m2 Exclusion criteria : Patient with cardiac disease, Diabetes, HTN , Peptic ulcer and duodenal ulcer, Cancer , Hepatic and Renal disorder , analgesic drugs intolerance , previous knee surgery or trauma or RA and previous treatment of PATB during last year
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of pain. Timepoint: Befor intervantion , 2 months after intervention. Method of measurement: Visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Befor intervantion , 2 months after intervention. Method of measurement: weight/(height)2. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJamileh Moghimi
Semnan University of Medical Sciences
Outcome results
None listed